BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2609765)

  • 1. [T-activin in the treatment of patients with recurrent erysipelas and concomitant eczema].
    Frolov VM; Peresadin NA; Gaĭdash IS; Baskakov IN; Tishchenko NA
    Vestn Dermatol Venerol; 1989; (9):47-51. PubMed ID: 2609765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
    Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
    Sov Med; 1990; (6):111-3. PubMed ID: 2144365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy].
    Iutskovskiĭ AD; Fedotov VP; Leshchenko GM
    Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
    Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic liver diseases: secondary thymic insufficiency and immunocorrection with T-activin].
    Sarkisian SV
    Klin Med (Mosk); 1994; 72(6):45-8. PubMed ID: 7898010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of vilozen on the immune status of erysipelas patients and the prospects for its use for the immune rehabilitation of convalescents].
    Frolov VM; Peresadin NA; Pinskiĭ LL; Korobka IuN
    Lik Sprava; 1992; (11-12):102-4. PubMed ID: 1292201
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
    Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
    Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [T-activin in the treatment of patients with recurrent aphthous stomatitis].
    Terekhova NV; Khazanova VV; Zemskaia EA; Bykova IA; Filonenko OF; Kosorukova NIa; Rabinovich IM
    Stomatologiia (Mosk); 1991; (2):35-7. PubMed ID: 1853375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of tactivin side effects in patient with eczema].
    Zaerko VV
    Klin Med (Mosk); 1991 May; 69(5):97-8. PubMed ID: 1857089
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI; Dudanova OP; Khavinson VKh
    Sov Med; 1990; (6):85-8. PubMed ID: 2396134
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of T-activin in the intensive therapy of the postoperative period in gestosis patients].
    Ianiushina VV
    Anesteziol Reanimatol; 1992; (4):42-5. PubMed ID: 1485674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrastructure of the blood lymphoid cells and the dynamics of cellular immunity indices in chronic lympholeukemia patients during immunocorrection with T-activin].
    Chuvirov GN; Markova TP
    Ter Arkh; 1986; 58(9):67-70. PubMed ID: 3787495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnostic and prognostic significance of the level of circulating immune complexes in patients with recurrent erysipelas].
    Frolov VM; Boĭchenko PK; Peresadin NA
    Vrach Delo; 1990 Jun; (6):116-8. PubMed ID: 2399704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
    Balabolkin MI; Arion VIa; Petunina NA
    Sov Med; 1987; (12):32-5. PubMed ID: 3502197
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunocorrecting therapy in focal scleroderma].
    Suchkova TN; Prozorovskaia NN; Suchkov SV; Del'vig AA
    Vestn Dermatol Venerol; 1987; (9):8-14. PubMed ID: 3424992
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and immunologic study on the efficacy of the leucotrophine treatment of patients with recurrent bronchopulmonary infections].
    Basacopol A; Popescu C; Esrig E; Nicolaescu O; Moldoveanu I; Bălună R; Belaşcu I; Eremia D; Ghyka P
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(1):63-8. PubMed ID: 2847302
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immune reactivity of patients with pulmonary tuberculosis suffering from chronic alcoholism].
    Mel'nik VP
    Vrach Delo; 1989 Apr; (4):82-5. PubMed ID: 2787943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of taktivin in patients with viral myocarditis and dilated cardiomyopathy].
    Kipshidze NN; Dzhaparidze MM; Dzidziguri LM; Rachvelishvili NB; Dateshidze MN; Demetrashvili MF
    Ter Arkh; 1990; 62(9):116-8. PubMed ID: 2177920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indices of cellular and humoral immunity in patients with disseminated sclerosis being treated with immunomodulators].
    Zapadniuk BV; Kravets AS; Iarosh AA; Shurinok LA
    Vrach Delo; 1988 Aug; (8):84-6. PubMed ID: 3206892
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of circulating immune complexes in patients with erysipelas].
    Frolov VM; Bala MA; Frolov AF; Rychnev VE
    Vrach Delo; 1985 Jun; (6):102-5. PubMed ID: 3161244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.